| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,440 |
5,984 |
$436K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,351 |
1,297 |
$75K |
| 87536 |
|
950 |
933 |
$60K |
| 86360 |
|
706 |
697 |
$25K |
| 36415 |
Collection of venous blood by venipuncture |
6,434 |
6,147 |
$24K |
| 99215 |
Prolong outpt/office vis |
256 |
249 |
$20K |
| 86359 |
|
706 |
697 |
$20K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
635 |
293 |
$15K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
634 |
292 |
$15K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
990 |
944 |
$10K |
| 86780 |
|
867 |
806 |
$9K |
| 90686 |
|
596 |
577 |
$8K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,248 |
1,220 |
$7K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
162 |
99 |
$6K |
| 91322 |
|
41 |
40 |
$5K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
45 |
45 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
358 |
352 |
$3K |
| 80061 |
Lipid panel |
280 |
278 |
$3K |
| 0124A |
|
99 |
92 |
$3K |
| 90834 |
Psychotherapy, 45 minutes with patient |
24 |
13 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
280 |
277 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
77 |
77 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
15 |
15 |
$2K |
| 99255 |
|
12 |
12 |
$2K |
| 82565 |
|
395 |
391 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
45 |
45 |
$996.18 |
| 90480 |
|
39 |
39 |
$906.52 |
| 0004A |
|
32 |
31 |
$874.22 |
| 0054A |
|
12 |
12 |
$541.92 |
| 86703 |
|
54 |
54 |
$477.10 |
| 80053 |
Comprehensive metabolic panel |
24 |
24 |
$224.08 |
| G0008 |
Administration of influenza virus vaccine |
29 |
29 |
$164.21 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
25 |
25 |
$137.00 |
| 82248 |
|
12 |
12 |
$53.10 |
| 84443 |
Thyroid stimulating hormone (TSH) |
13 |
13 |
$0.00 |